论文部分内容阅读
目的:探讨博莱霉素A5、碘化油、地塞米松、利多卡因(BIDL)四联药物治疗海绵状血管瘤的临床效果。方法:对88例海绵状血管瘤行BIDL四联药物瘤腔注射,观察瘤体变化并定期随访。结果:BIDL四联药物治疗海绵状血管瘤88例经1年后复查治愈率90.9%,有效率100%。结论:BIDL四联药物疗法可作为海绵状血管瘤保守治疗的首选方法。
Objective: To investigate the clinical effects of Bleomycin A5, iodized oil, dexamethasone and lidocaine (BIDL) quadruple drug in the treatment of cavernous hemangiomas. Methods: Eighty - eight cases of cavernous hemangiomas were injected with tumor - bearing BIDL quadruple drug. The changes of the tumor were observed and followed up regularly. Results: Eighty-eight patients with cavernous hemangiomas treated by BIDL quadruple drug therapy had a cure rate of 90.9% after 1 year and the effective rate was 100%. Conclusion: BIDL quadruple drug therapy can be used as conservative treatment of cavernous hemangioma preferred method.